Futureco Bioscience names María José Lis Chief Commercial Officer

SPAIN – Futureco Bioscience has promoted María José Lis to Chief Commercial Officer as the biotechnology company reorganizes its commercial division to strengthen international growth and reinforce support for farmers and distributors.

Lis has been part of Futureco Bioscience for the past five years, where she led Business Development and Marketing. During this period, she played a central role in shaping the company’s presence in Mexico, Brazil, North Africa, Asia, and other important markets.

Her international experience and deep knowledge of the company prepared her to take charge of the next stage of commercial development.

In her new position, Lis will focus on creating a more integrated structure across the commercial teams. She will also prioritize efficiency, closer collaboration, and stronger ties with clients and distributors.

Rafael Juncosa, President & CEO of Futureco Bioscience, stressed the importance of the appointment. He said, “Her appointment responds to the need for a more integrated and synergistic commercial structure across countries. This restructuring aims at greater efficiency, stronger collaboration, and a closer relationship with our customers. With her experience and the support of the entire team, we are confident this new stage will be key to advancing our mission.”

The company emphasized that Lis’s promotion also reflects a broader value: recognition of talent, experience, and diverse leadership. Futureco Bioscience believes that women are playing an increasingly important role in shaping sustainable agriculture.

Speaking on her appointment, Lis said, “I am honored to take on this new responsibility at such an exciting stage for Futureco Bioscience. My focus will be on reinforcing our relationships with clients and distributors worldwide while broadening our horizons, so that our innovations consistently translate into practical solutions and value in the field.”

Headquartered in Olérdola, Barcelona, Futureco Bioscience operates in more than 50 countries. The company develops biocontrol and biostimulant solutions that improve crop resilience, reduce environmental impact, and strengthen the productivity of export-oriented agriculture.

The company also recently expanded its innovation center, adding new laboratories dedicated to formulation and microbiology.

This step supports its mission to combine research with practical applications that address challenges in global agriculture. With the appointment of Lis, Futureco Bioscience reinforces its commercial strategy while continuing to invest in science-driven solutions for farmers across the world.

Sign up to receive our email newsletters with the latest news updates and insights from Africa and the World HERE.